Stock listing
OTC:PKTX ProtoKinetix, Inc. Stock
Follow ProtoKinetix, Inc. into a list and get an email when it puts out news.
Share price · OTC:PKTX
$0.0020 USD 0.0000 (0.0%)
Close on Nov 12, 2026
- Day range
- $0.0020 – $0.0020 USDNov 12, 2026
- Market cap
- $823,260 USDAt the close on Nov 12, 2026 · price × 411.6M shares outstanding
- 52-week range
- $0.0001 – $0.0124 USDLowest and highest trades, Nov 13, 2025 – Nov 12, 2026
- Traded on an average day
- $8 USDMedian day 0 shares · 49 days with no trades · last 3 months, Aug 12, 2026 – Nov 12, 2026

Daily closes
Last 3 months, Aug 12, 2026 – Nov 12, 2026 · OTC:PKTX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.0020 | 0.0000 | 0.0% | $0.0020 | $0.0020 | $0.0020 | 0 | |
| $0.0020 | 0.0000 | 0.0% | $0.0020 | $0.0020 | $0.0020 | 0 | |
| $0.0020 | +0.0018 | +900.0% | $0.0020 | $0.0020 | $0.0020 | 2,500 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | -0.0001 | -33.3% | $0.0001 | $0.0002 | $0.0001 | 3,000 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 12,000 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | -0.0001 | -25.0% | $0.0003 | $0.0003 | $0.0003 | 100 | |
| $0.0004 | +0.0002 | +100.0% | $0.0004 | $0.0004 | $0.0004 | 550,000 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | +0.0001 | +100.0% | $0.0002 | $0.0002 | $0.0002 | 160,000 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | -0.0001 | -50.0% | $0.0001 | $0.0001 | $0.0001 | 50,000 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 230 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 5,000 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 6,000 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 1,000 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 1,000 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 20,458 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | -0.0003 | -60.0% | $0.0002 | $0.0002 | $0.0002 | 50,000 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 0 | |
| $0.0005 | +0.0001 | +25.0% | $0.0002 | $0.0005 | $0.0002 | 400,000 |
Splits
1 split · OTC:PKTX · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 5-for-2 | Split |
- Ticker
- OTC:PKTX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Nov 5, 2026
Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)
Latest news
Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)
Nov 4, 2026
Closed $0.0003 (0.0%) on Nov 5, 2026
Annual Report for Fiscal Year Ending December 31, 2025 (Form 10-K)
Sep 3, 2026
Closed $0.0002 (0.0%) on Sep 4, 2026
ProtoKinetix, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 3 in the last 12 months · 69 in all · newest Nov 5, 2026 · oldest 2009
- Decks
- 4 decks · latest Feb 11, 2022
Valuation
Price/book 3.3× against a median of 0.3×: 10th lowest of 11 Biotechnology companies shown. Statements: Year to Dec 31, 2025 · balance Sep 30, 2026 · price Nov 12, 2026
- Enterprise value
- $822,736 USD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- Negative EBITDA
- Price/book
- 3.3×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 0.61
Biotechnology: the 10 companies nearest in size, of 891 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| ProtoKinetix, Inc. · OTC:PKTX | US$823,260 | US$822,736 | n/a | n/a | n/a | 3.3× | n/a | 0.0× | 0.61 |
| SureNano Science Ltd · CSE:SURE | US$1.17M | US$672,321 | n/a | n/a | n/a | 0.3× | n/a | 0.0× | 0.25 |
| Valion Bio, Inc. · NASDAQ:VBIO | US$1.04M | US$16.34M | n/a | 42.8× | n/a | 0.2× | n/a | 4.1× | 1.11 |
| GeoVax Labs, Inc. · NASDAQ:GOVX | US$985,460 | −US$915,033 | n/a | n/a | n/a | 0.9× | n/a | 0.2× | 1.47 |
| Biodexa Pharmaceuticals plc · NASDAQ:BDRX | US$982,950 | −US$3.22M | n/a | n/a | n/a | 0.1× | n/a | 0.0× | 1.01 |
| Gabather AB · OMXSTO:GABA | US$919,514 | US$559,105 | n/a | n/a | n/a | 6.4× | n/a | 0.0× | n/a |
| ExpreS2ion Biotech Holding AB · OMXSTO:EXPRS2 | US$792,634 | −US$2.43M | n/a | −6.5× | n/a | 0.2× | −935.9% | 0.0× | n/a |
| Silexion Therapeutics Corp · NASDAQ:SLXN | US$790,001 | −US$3.60M | n/a | n/a | n/a | 0.3× | n/a | 0.1× | 2.77 |
| Oragenics Inc. · AMEX:OGEN | US$708,377 | −US$1.12M | n/a | n/a | n/a | 0.7× | n/a | 0.4× | 1.47 |
| Protagenic Therapeutics, Inc. · OTC:PTIX | US$687,879 | US$610,970 | 0.1× | n/a | n/a | 0.6× | n/a | 0.0× | 1.21 |
| Lakewood-Amedex Biotherapeutics Inc. · NASDAQ:LABT | US$580,337 | −US$2.74M | n/a | n/a | n/a | 0.2× | n/a | 0.0× | 0.46 |
| Median of the others | US$856,074 | −US$1.02M | 0.1× | 18.1× | 0.3× | −935.9% | 0.0× | 1.16 |
Team and board
Officers
| Officer | Role |
|---|---|
| Mike Guzzetta | Chairman, President, CEO & CFO |
Board
| Director | Role |
|---|---|
| Mike Guzzetta | Chairman, President, CEO & CFO |
| Edward P. McDonough | Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2025 | Nov 13, 2025 | −2.9% |
| Q2 2025 | Aug 13, 2025 | 0.0% |
| Q1 2025 | May 13, 2025 · Before open | +13.6% |
| Q4 2024 | Mar 18, 2025 · After close | +31.7% |
| Q3 2024 | Nov 1, 2024 · Before open | +28.1% |
| Q2 2024 | Jul 30, 2024 · Before open | +28.2% |
| Q1 2024 | May 15, 2024 · Before open | +11.3% |
| Q4 2023 | Mar 20, 2024 · After close | −12.6% |
| Q3 2023 | Oct 18, 2023 · Before open | −10.3% |
| Q2 2023 | Jul 14, 2023 · After close | +4.8% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2023 | May 2, 2023 · Before open | +11.0% |
| Q4 2022 | Mar 17, 2023 · After close | +3.6% |
| Q3 2022 | Oct 31, 2022 · After close | +9.6% |
| Q2 2022 | Jul 29, 2022 · After close | −2.2% |
| Q1 2022 | May 10, 2022 · After close | −9.5% |
| Q4 2021 | Mar 10, 2022 | −0.5% |
| Q3 2021 | Nov 12, 2021 | −3.2% |
| Q2 2021 | Jul 28, 2021 | +2.5% |
| Quarter to Mar 31, 2021 | Apr 16, 2021 | −2.5% |
| Quarter to Dec 31, 2020 | Mar 5, 2021 | +20.7% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Shareholder Meeting (February 2022) | Shareholder meeting | 24 slides | Feb 11, 2022 |
| Investor Presentation (September 2020) | Investor deck | 26 slides | September 2020 |
| Investor Presentation (June 2019) | Investor deck | 20 slides | June 2019 |
| Technical Presentation (March 2010) | Technical | 30 slides | March 2010 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | 52.9K | 48.3K | 58.5K | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K | |
| Gross profit | -52.9K | -48.3K | -58.5K | -3.00K | -3.00K | -3.00K | -3.00K | -3.00K | -3.00K | |
| Research and development | 106.6K | 99.6K | 112.4K | 448.9K | 435.9K | 527.3K | 369.5K | 337.1K | 296.5K | 450.9K |
| Selling, general and administrative | 235.7K | 206.3K | 254.8K | 1.40M | 1.89M | 7.11M | 3.83M | 876.0K | 1.21M | 1.07M |
| Operating income | -393.6K | -311.0K | -367.0K | -1.85M | -2.33M | -7.64M | -4.19M | -1.22M | -1.51M | -1.52M |
| Depreciation and amortization | 51.3K | 52.9K | 48.3K | 58.5K | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
| EBITDA | -342.4K | -258.1K | -318.7K | -1.79M | -2.33M | -7.64M | -4.19M | -1.21M | -1.51M | -1.52M |
| Interest expense | 0 | 0 | 0 | 306 | 1.66K | 12 | ||||
| Income before tax | -393.6K | -364.0K | -415.0K | -1.91M | -2.33M | -7.64M | -4.20M | -1.22M | -1.51M | -1.52M |
| Income tax | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | -393.6K | -364.2K | -415.5K | -1.91M | -2.33M | -7.64M | -4.20M | -1.22M | -1.51M | -1.52M |
| Earnings per share, basic | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 | -0.03 | -0.02 | 0.00 | -0.01 | -0.01 |
| Earnings per share, diluted | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 | -0.03 | -0.02 | 0.00 | -0.01 | -0.01 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.12K | 4.70K | 20.4K | 25.6K | 57.6K | 193.4K | 377.4K | 136.0K | 302.9K | 371.0K |
| Short-term investments | 0 | 0 | 0 | |||||||
| Receivables | 0 | |||||||||
| Inventory | 0 | 0 | 0 | |||||||
| Current assets | 2.17K | -3.65K | 21.5K | 26.6K | 83.6K | 194.5K | 378.4K | 137.1K | 365.1K | 441.4K |
| Property, plant and equipment | 0 | 0 | 0 | |||||||
| Goodwill | 0 | 0 | 0 | |||||||
| Total assets | 483.4K | 466.1K | 480.6K | 462.9K | 446.2K | 469.2K | 585.9K | 324.9K | 518.1K | 542.1K |
| Accounts payable | 185.4K | 124.0K | 44.7K | 41.5K | 93.3K | 45.0K | 26 | 78.9K | 26.9K | 45.2K |
| Current liabilities | 185.4K | 124.0K | 44.7K | 41.5K | 93.3K | 45.0K | 0 | 78.9K | 144.6K | 45.3K |
| Long-term debt | 0 | 0 | 0 | |||||||
| Total debt | 117.7K | |||||||||
| Total liabilities | 185.4K | 124.0K | 44.7K | 41.5K | 93.3K | 45.0K | 25.5K | 78.9K | 144.6K | 45.3K |
| Shareholders' equity | 297.9K | 342.1K | 435.9K | 421.3K | 353.0K | 424.2K | 560.4K | 246.0K | 373.6K | 496.8K |
| Shares outstanding | 406.8M | 371.9M | 346.2M | 322.9M | 297.4M | 286.0M | 275.4M | 259.8M | 251.4M | 238.0M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -135.4K | -223.1K | -376.0K | -804.7K | -889.9K | -881.3K | -850.7K | -453.5K | -605.1K | -820.3K |
| Capital spending | -56.3K | -58.1K | -59.2K | -132.0K | -91.0K | -70.2K | -25.0K | -35.5K | -59.0K | -29.8K |
| Free cash flow | -191.7K | -223.1K | -435.1K | -936.7K | -980.9K | -951.5K | -875.7K | -489.0K | -664.1K | -850.0K |
| Cash from investing | -56.3K | -58.1K | -59.2K | -132.0K | -91.0K | -70.2K | -25.0K | -35.5K | 57.0K | -29.8K |
| Cash from financing | 197.5K | 256.0K | 430.0K | 904.7K | 845.0K | 767.6K | 1.12M | 322.0K | 480.0K | 850.0K |
| Dividends paid | 0 | 0 | 0 | |||||||
| Share buybacks | 0 | 168 | 20 | |||||||
| Change in cash | 5.82K | -25.1K | -5.14K | -32.0K | -135.9K | -183.9K | 241.3K | -166.9K | -68.1K | -43 |
Cap table
Built by 6ix from ProtoKinetix, Inc.’s releases · as of Sep 2, 2026
- Common shares
- 411,630,152
- Fully diluted
- 411,630,152
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 411,630,152 | Sep 2, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Sep 2, 2026 | 411,630,152 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mark L. Baum Other companies: Harrow, Inc. (Chief Executive Officer and Chairman of the Board of Directors · Since at least Dec 12, 2011); Eton Pharmaceuticals, Inc. (Director · Nov 9, 2018 – Mar 12, 2020 · Past); Ideal Power Inc. (Director · Nov 21, 2013 – Mar 3, 2017 · Past) | President, Director · May 28, 2007 – May 28, 2007 · Past |
| Michael Guzzetta Other companies: Integral Technologies Inc (CFO · Sep 19, 2018 – Sep 19, 2018 · Past) | Chairman, President, CEO & CFO · Since at least Nov 14, 2017 |
| Clarence E. Smith | President & CEO, Director · Since at least Nov 2, 2020 |
| Edward P. McDonough | Director · Since at least Jul 1, 2015 |
| Jason G Lamp | Director · Since at least Jun 17, 2026 |
| Keith R Brunt | President, Director · Since at least Jun 17, 2026 |
| Michael Winston Jones | Director · Since at least Jun 17, 2026 |
| Ross Laurence Senior | CEO, Director · Sep 12, 2014 – Sep 12, 2014 · Past |
Log in to ask 6ix AI your own questions about ProtoKinetix, Inc.